Filing Details
- Accession Number:
- 0001567619-21-012540
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-23 17:12:13
- Reporting Period:
- 2021-06-23
- Accepted Time:
- 2021-06-23 17:12:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533743 | Processa Pharmaceuticals Inc. | PCSA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378166 | David Young | C/O Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive, Suite 106 Hanover MD 21076 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-23 | 10,000 | $7.67 | 345,190 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 548,783 | Indirect | By Young-Plaisance Revocable Trust |
| Common Stock | 689,004 | Indirect | By Family Entities |
| Common Stock | 55,258 | Indirect | By CorLyst, LLC |
Billionaire Hedge Funds
